Menarini Asia-Pacific Enters into an Exclusive Licensing Agreement with Astellas to Commercialize Smyraf® in Taiwan and select South-East Asian markets ...Middle East

SINGAPORE, Sept. 12, 2023 /PRNewswire/ -- Menarini Asia-Pacific has entered into a long-term exclusive licensing partnership with Astellas Pharma Inc. (Astellas) for the development, manufacturing and commercialization of the orally administered Janus kinase (JAK) inhibitor Smyraf® 50 mg...

Hence then, the article about menarini asia pacific enters into an exclusive licensing agreement with astellas to commercialize smyraf in taiwan and select south east asian markets was published today ( Wednesday 13/09/2023 - 05:36 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Menarini Asia-Pacific Enters into an Exclusive Licensing Agreement with Astellas to Commercialize Smyraf® in Taiwan and select South-East Asian markets )

Also on site :

• 49 Years Later: The Most Heartbreaking Quotes About the Day Elvis Presley Died, From the Women Who Loved Him
• This Iconic ‘Old Florida’ Attraction Has Been Welcoming Families Since 1949—Here’s What Makes It So Special Today
• Pixar Announces ‘Cars’ and ‘Coco’ TV and Film Sequels, Video Games and Expansions Across Disney Parks at D23 2026